A network study of chinese medicine xuesaitong injection to elucidate a complex mode of action with multicompound, multitarget, and multipathway

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Wang, Linli ^a   Li, Zheng ^b   Zhao, Xiaoping ^b,c   Liu, Wei ^a   Liu, Yufeng ^a   Yang, Jihong ^a   Li, Xiang ^a   Fan, Xiaohui ^a   Cheng, Yiyu ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHINESE DRUG; UNCLASSIFIED DRUG; XUESAITONG INJECTION;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHINESE MEDICINE; CONTROLLED STUDY; DRUG MECHANISM; GENE EXPRESSION; HEART INFARCTION; IN VITRO STUDY; MALE; NONHUMAN; PANAX NOTOGINSENG; PRIORITY JOURNAL; RAT; TRANSCRIPTOMICS;

EID: 84884227079     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/652373     Document Type: Article

References (46)

1. Xu J., Wu H., Chinese herbal medicine and acupuncture for the treatment of cardiovascular disease. Journal of Geriatric Cardiology 2009 6 1 56 61 2-s2.0-78649286559
2. Han D., Liao F. L., Chinese medicine, flowing blood, biomechanopharmacology and future preventive medicine. Chinese Science Bulletin 2012 57 27 3541 3546 10.1007/s11434-012-5226-8
3. Liu S., Yi L. Z., Liang Y. Z., Traditional Chinese medicine and separation science. Journal of Separation Science 2008 31 11 2113 2137 2-s2.0-48949117179 10.1002/jssc.200800134
4. Cheung F., TCM: made in China. Nature 2011 480 7378 S82 S83 2-s2.0-84055193535 10.1038/480S82a
5. Pan S.-Y., Chen S.-B., Dong H.-G., Yu Z.-L., Dong J.-C., Long Z.-X., Fong W.-F., Han Y.-F., Ko K.-M., New perspectives on Chinese herbal medicine (Zhong-Yao) research and development. Evidence-based Complementary and Alternative Medicine 2011 2011 11 2-s2.0-78650367941 10.1093/ecam/neq056 403709
6. Li S., Zhang B., Zhang N., Network target for screening synergistic drug combinations with application to traditional Chinese medicine. BMC Systems Biology 2011 5 supplement 1, article S10 2-s2.0-79959199033 10.1186/1752-0509-5- S1-S10
7. Graziose R., Lila M. A., Raskin I., Merging traditional Chinese medicine with modern drug discovery technologies to find novel drugs and functional foods. Current Drug Discovery Technologies 2010 7 1 2 12 2-s2.0-77951744892 10.2174/157016310791162767
8. Zhao J., Jiang P., Zhang W., Molecular networks for the study of TCM pharmacology. Briefings in Bioinformatics 2009 11 4 417 430 2-s2.0-77955039434 10.1093/bib/bbp063
9. Lin J., Wei L., Xu W., Hong Z., Liu X., Peng J., Effect of Hedyotis Diffusa Willd extract on tumor angiogenesis. Molecular Medicine Reports 2011 4 6 1283 1288 2-s2.0-80053092669 10.3892/mmr.2011.577
10. Efferth T., Koch E., Complex interactions between Phytochemicals. The multi-target therapeutic concept of phytotherapy. Current Drug Targets 2011 12 1 122 132 2-s2.0-78650912735 10.2174/138945011793591626
11. Wang Y., Liu Y., Liu Z., Yin J., The quality control of the effective fraction from Dioscorea spongiosa. Asian Journal of Traditional Medicines 2007 2 1 12 18
12. Tao W., Xu X., Wang X., Li B., Wang Y., Li Y., Yang L., Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease. Journal of Ethnopharmacology 2012 145 1 1 10 10.1016/j.jep.2012.09.051
13. Wang Y., Liu Z., Li C., Li D., Ouyang Y., Yu J., Guo S., He F., Wang W., Drug target prediction based on the herbs components: the study on the multitargets pharmacological mechanism of Qishenkeli acting on the coronary heart disease. Evidence-Based Complementary and Alternative Medicine 2012 2012 10 2-s2.0-84859770257 10.1155/2012/698531 698531
14. Chen S.-L., Jiang J.-G., Application of gene differential expression technology in the mechanism studies of nature product-derived drugs. Expert Opinion on Biological Therapy 2012 12 7 823 839 10.1517/14712598.2012.683858
15. Barabási A. L., Gulbahce N., Loscalzo J., Network medicine: a network-based approach to human disease. Nature Reviews Genetics 2011 12 1 56 68 2-s2.0-78650373804 10.1038/nrg2918
16. Hopkins A. L., Network pharmacology. Nature Biotechnology 2007 25 10 1110 1111 2-s2.0-35148824614 10.1038/nbt1007-1110
17. Arrell D. K., Terzic A., Network systems biology for drug discovery. Clinical Pharmacology & Therapeutics 2010 88 1 120 125 2-s2.0-77953811662 10.1038/clpt.2010.91
18. Wu L., Wang Y., Nie J., Fan X., Cheng Y., A network pharmacology approach to evaluating the efficacy of Chinese medicine using genome-wide transcriptional expression data. Evidence-Based Complementary and Alternative Medicine 2013 2013 8 10.1155/2013/915343 915343
19. Yao H., Shi P., Shao Q., Fan X., Chemical fingerprinting and quantitative analysis of a Panax notoginseng preparation using HPLC-UV and HPLC-MS. Chinese Medicine 2011 6, article 9 2-s2.0-79951960669 10.1186/1749-8546-6-9
20. Wang S., Zhu Q., Yi L., The effect of xuesaitong injection on C-reactive protein in patients with acute coronary syndrome. Medical Recapitulate 2007 8 37
21. De-liang Y., Curative effect of xuesaitong injection on acute cerebral infarction of 50 patients. Practical Clinical Medicine 2007 12 12
22. Balin C., Xinde L., Fang W., Protective effects of xuesaitong injection on myocardial ischemic reperfusion injury in rats. Guizhou Medical Journal 2007 1 4
23. Wei H., Xiao-jun X., Attenuation of brain inflammatory response after focal cerebral ischemia/reperfusion with xuesaitong injection in rats. Chinese Journal of Integrative Medicine 2006 12 3 203 206 2-s2.0-33749580966
24. Ai W., Chen Y., Yang Q., Clinical observation on effect of xuesaitong injection as auxiliary treatment of severe craniocerebral injury. Chinese Journal of Integrated Traditional and Western Medicine 2004 24 3 213 215 2-s2.0-3142680778
25. Kangyu C., Zuo W., Li L., Clinical study on effect of xuesaitong injection on pulmonary artery pressure and coagulation in patients with cor pulmonale during acute attack. Journal of Emergency in Traditional Chinese Medicine 2003 3 33
26. Huilian G., Clinical observation on curing cerebral embolism by xuesaitong & salvia miltiorrhiza compound injections. Journal of Medical Forum 2003 6 6
27. Deng Y. Q., Fan X. F., Li Y. D., Clinical observation of the effect of xuesaitong soft capsule (Chinese characters) on post-hepatitis fibrosis. Chinese Journal of Integrative Medicine 2005 11 1 11 14 2-s2.0-19944370459
28. Twigger S., Lu J., Shimoyama M., Chen D., Pasko D., Long H., Ginster J., Chen C.-F., Nigam R., Kwitek A., Eppig J., Maltais L., Maglott D., Schuler G., Jacob H., Tonellato P. J., Rat Genome Database (RGD): mapping disease onto the genome. Nucleic Acids Research 2002 30 1 125 128 2-s2.0-18444394318
29. Tong W., Cao X., Harris S., Sun H., Fang H., Fuscoe J., Harris A., Hong H., Xie Q., Perkins R., Shi L., Casciano D., Array track-supporting toxicogenomic research at the U.S. Food and Drug Administration National Center for Toxicological Research. Environmental Health Perspectives 2003 111 15 1819 1826 2-s2.0-0346243568
30. Ogata H., Goto S., Sato K., Fujibuchi W., Bono H., Kanehisa M., KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Research 1999 27 1 29 34 2-s2.0-0032919364 10.1093/nar/27.1.29
31. Shannon P., Markiel A., Ozier O., Baliga N. S., Wang J. T., Ramage D., Amin N., Schwikowski B., Ideker T., Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Research 2003 13 11 2498 2504 2-s2.0-0242490780 10.1101/gr.1239303
32. Zhang Y., Köhler K., Xu J., Lu D., Braun T., Schlitt A., Buerke M., Müller-Werdan U., Werdan K., Ebelt H., Inhibition of p53 after acute myocardial infarction: reduction of apoptosis is counteracted by disturbed scar formation and cardiac rupture. Journal of Molecular and Cellular Cardiology 2011 50 3 471 478 2-s2.0-79551602745 10.1016/j.yjmcc.2010.11.006
33. Webster K. A., Mitochondrial membrane permeabilization and cell death during myocardial infarction: roles of calcium and reactive oxygen species. Future Cardiology 2012 8 6 863 884 10.2217/fca.12.58
34. Zhang L., Li X., Tai J., Li W., Chen L., Predicting candidate genes based on combined network topological features: a case study in coronary artery disease. PLoS ONE 2012 7 6 e39542 10.1371/journal.pone.0039542
35. Pawlinski R., Mackman N., Tissue factor and heart inflammation. Journal of Thrombosis and Haemostasis 2009 7 2 288 289 2-s2.0-59049101724 10.1111/j.1538-7836.2008.03257.x
36. Lee W. W., Marinelli B., van der Laan A. M., Sena B. F., Gorbatov R., Leuschner F., Dutta P., Iwamoto Y., Ueno T., Begieneman M. P. V., Niessen H. W. M., Piek J. J., Vinegoni C., Pittet M. J., Swirski F. K., Tawakol A., Di Carli M., Weissleder R., Nahrendorf M., PET/MRI of inflammation in myocardial infarction. Journal of the American College of Cardiology 2012 59 2 153 163 2-s2.0-84855363554 10.1016/j.jacc.2011.08.066
37. Chen L.-L., Zhu T. B., Yin H., Huang J., Wang L. S., Cao K. J., Yang Z. J., Inhibition of MAPK signaling by eNOS gene transfer improves ventricular remodeling after myocardial infarction through reduction of inflammation. Molecular Biology Reports 2010 37 7 3067 3072 2-s2.0-77956959192 10.1007/s11033-009-9879-6
38. Shi C., Awad I. A., Jafari N., Lin S., Du P., Hage Z. A., Shenkar R., Getch C. C., Bredel M., Batjer H. H., Bendok B. R., Genomics of human intracranial aneurysm wall. Stroke 2009 40 4 1252 1261 2-s2.0-65249164805 10.1161/STROKEAHA.108.532036
39. Meng W., Takeichi M., Adherens junction: molecular architecture and regulation. Cold Spring Harbor Perspectives in Biology 2009 1 6 a002899 2-s2.0-77149179101 10.1101/cshperspect.a002899
40. Lisewski U., Shi Y., Wrackmeyer U., Fischer R., Chen C., Schirdewan A., Jüttner R., Rathjen F., Poller W., Radke M. H., Gotthardt M., The tight junction protein CAR regulates cardiac conduction and cell-cell communication. The Journal of Experimental Medicine 2008 205 10 2369 2379 2-s2.0-53349097084 10.1084/jem.20080897
41. Ruiz-Ortega M., Rodríguez-Vita J., Sanchez-Lopez E., TGF- β signaling in vascular fibrosis. Cardiovascular Research 2007 74 2 196 206 2-s2.0-34047156556 10.1016/j.cardiores.2007.02.008
42. Cohen E. D., Tian Y., Morrisey E. E., Wnt signaling: an essential regulator of cardiovascular differentiation, morphogenesis and progenitor self-renewal. Development 2008 135 5 789 798 2-s2.0-42149159492 10.1242/dev.016865
43. Goodwin A. M., D'Amore P. A., Wnt signaling in the vasculature. Angiogenesis 2002 5 1-2 1 9 2-s2.0-0036937945 10.1023/A:1021563510866
44. Xu Y., Li X., Zhou M., Neuregulin-1/ErbB signaling: a druggable target for treating heart failure. Current Opinion in Pharmacology 2009 9 2 214 219 2-s2.0-62249192069 10.1016/j.coph.2008.11.004
45. Lee S., Chen T. T., Barber C. L., Jordan M. C., Murdock J., Desai S., Ferrara N., Nagy A., Roos K. P., Iruela-Arispe M. L., Autocrine VEGF signaling is required for vascular homeostasis. Cell 2007 130 4 691 703 2-s2.0-34547941252 10.1016/j.cell.2007.06.054
46. Zhang S., Weinheimer C., Courtois M., Kovacs A., Zhang C. E., Cheng A. M., Wang Y., Muslin A. J., The role of the Grb2-p38 MAPK signaling pathway in cardiac hypertrophy and fibrosis. The Journal of Clinical Investigation 2003 111 6 833 841 2-s2.0-0037364622 10.1172/JCI200316290